A Comparison of Native and Modified Intravenous Immunoglobulin for the Management of Hypogammaglobulinemia
- 28 February 1987
- journal article
- clinical trial
- Published by Elsevier in The Lancet Healthy Longevity
- Vol. 293 (2), 69-74
- https://doi.org/10.1097/00000441-198702000-00001
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Intravenous immune globulin for hypogammaglobulinemia: A comparison of opsonizing capacity in recipient seraClinical Immunology and Immunopathology, 1985
- Efficacy of Intravenous Immunoglobulin in Primary Humoral Immunodeficiency DiseaseAnnals of Internal Medicine, 1984
- Correlation Between Opsonic Activity for Various Microorganisms and Composition of Gammaglobulin Preparations for Intravenous UseThe Journal of Infectious Diseases, 1984
- Intravenous use of gammaglobulin in the treatment of chronic immune thrombocytopenic purpura as a means to defer splenectomyThe Journal of Pediatrics, 1983
- Use of intravenous γ-globulin in antibody immunodeficiency: Results of a multicenter controlled trialClinical Immunology and Immunopathology, 1982
- SAFETY AND PATIENT ACCEPTABILITY OF INTRAVENOUS IMMUNE GLOBULIN IN 10% MALTOSEThe Lancet, 1980
- Two nephelometric methods compared with a radial immunodiffusion method for the measurement of IgG, IgA and IgMClinical Biochemistry, 1980
- THE ADSORPTION OF PROTEINS ON ERYTHROCYTES TREATED WITH TANNIC ACID AND SUBSEQUENT HEMAGGLUTINATION BY ANTIPROTEIN SERAThe Journal of Experimental Medicine, 1951
- "GAMMA GLOBULIN" AND "PLACENTAL GLOBULIN"JAMA, 1944